Sort
23,748 grants matching “melanoma”
Immune Therapy for Brain Metastasis
$583,091Lucia Beatrice Jilaveanu · Yale University · R01 · FY2023 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy.
$582,940Mary L. Disis · University Of Washington · R01 · FY2009 · CA
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
$582,917Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2018 · CA
Phase II Clinical Development of Galectin-3 Inhibition and Anti-PD-1: Immune Monitoring and Tumor Response
$582,888Brendan D Curti · Providence Portland Medical Center · R01 · FY2023 · CA
Role of IRF2 in cancer immune evasion and immunotherapy
$582,872Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA
Role of IRF2 in cancer immune evasion and immunotherapy
$582,872Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · CA
Molecular mechanisms underlying lineage plasticity in prostate cancer
$582,713Himisha Beltran · Dana-Farber Cancer Inst · R37 · FY2023 · CA
Mouse modeling of HPV infection
$582,604Chien-Fu Hung · Johns Hopkins University · R01 · FY2022 · CA
Combating melanoma resistance by targeting ABL1/2
$582,247Rina Plattner · University Of Kentucky · R01 · FY2025 · CA
Social Health, Activity Behaviors, and Quality of Life among Young Adult Cancer Survivors: A Longitudinal Study
$582,043Kimberly Ann Miller · University Of Southern California · R37 · FY2024 · CA
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse
$581,811Svetomir Nenad Markovic · Mayo Clinic Rochester · R01 · FY2024 · CA
Using Clonal and Non-Clonal UV Signature Mutations to Predict Skin Cancer Risk
$581,769Douglas E Brash · Yale University · R01 · FY2021 · CA
A personalized approach to skin cancer prevention among adolescents
$581,747Yelena Ping Wu · University Of Utah · R01 · FY2021 · CA
Mouse modeling of HPV infection
$581,637Chien-Fu Hung · Johns Hopkins University · R01 · FY2023 · CA
Developing new immunotherapies based of CD4+ T cells
$581,621Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Correlative biomarkers of IL-6 blockade combined with checkpoint inhibition
$581,524Jeffrey S Weber · New York University School Of Medicine · R01 · FY2023 · CA
Correlative biomarkers of IL-6 blockade combined with checkpoint inhibition
$581,524Jeffrey S Weber · New York University School Of Medicine · R01 · FY2022 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$581,426Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Lymphocyte signaling and immune cell response
$581,362Tasha Morrison · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Intravital Microscopy Core
$581,355Roberto Weigert · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Intrinsic and Extrinsic factors regulating competition for active TGFb promote skin memory CD8 T cell fitness
$581,349Daniel H Kaplan · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AR
ROLE AND REGULATION OF FOXD3 IN MUTANT B-RAF MELANOMA
$581,250Thomas Jefferson University · · FY2011 · Department of the Army
Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer
$581,244Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Overcoming Immunotherapy Resistance Through Opioid Antagonism in Head and Neck Cancer
$581,147Nicole N Scheff · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)
$581,127Mohamed H. Abdel-Rahman · Ohio State University · R01 · FY2021 · CA